M. Padmaja Bhattacharya

No ORCID on file · 3 papers in corpus · active 2022-2023

Study types

  • article 2
  • rct 1

Condition tags

  • adenomyosis 3
  • dysmenorrhea 2
  • infertility 1
rct 2023
Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.03.010

RESEARCH QUESTION: Can low-dose letrozole reduce dysmenorrhoea, menorrhagia and sonographic features in symptomatic women with adenomyosis awaiting IVF? DESIGN: This was a longitudinal randomized prospective pilot study to explore the effe…

article 2023
P-358 Impact of localization of diffuse adenomyosis on reproductive outcomes and pregnancy complications: A prospective cohort study of 585 patients after frozen embryo replacement cycle
·doi:10.1093/humrep/dead093.716

Abstract Study question Does localization of diffuse adenomyosis impact reproductive outcomes after the frozen embryo transfer (FET)? Summary answer Diffuse adenomyotic lesions involving the junctional zone (JZ) have a greater negative impa…

article 2022
P-324 Effectiveness of letrozole in symptomatic women with adenomyosis undergoing IVF: An overview of clinical features, sonographic characteristics, and reproductive outcome
·doi:10.1093/humrep/deac107.308

Abstract Study question Is letrozole pre-treatment a cost-effective option in improving symptoms, sonographic features, and reproductive outcomes in women with adenomyosis, undergoing IVF treatment? Summary answer Only two months of low dos…